GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Danaher Corp (NYSE:DHRpA.PFD) » Definitions » Total Liabilities

DHRPA.PFD (Danaher) Total Liabilities : $28,259.00 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Danaher Total Liabilities?

Danaher's Total Liabilities for the quarter that ended in Mar. 2025 was $28,259.00 Mil.

Danaher's quarterly Total Liabilities declined from Sep. 2024 ($29,310.00 Mil) to Dec. 2024 ($27,992.00 Mil) but then increased from Dec. 2024 ($27,992.00 Mil) to Mar. 2025 ($28,259.00 Mil).

Danaher's annual Total Liabilities declined from Dec. 2022 ($34,260.00 Mil) to Dec. 2023 ($30,998.00 Mil) and declined from Dec. 2023 ($30,998.00 Mil) to Dec. 2024 ($27,992.00 Mil).


Danaher Total Liabilities Historical Data

The historical data trend for Danaher's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danaher Total Liabilities Chart

Danaher Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36,384.00 38,007.00 34,260.00 30,998.00 27,992.00

Danaher Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29,955.00 28,653.00 29,310.00 27,992.00 28,259.00

Danaher Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Danaher's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6798+(16468+220
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+232+849+3425)
=27,992.00

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=77542-49550
=27,992.00

Danaher's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6645+(15976+5638
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+3425)
=28,259.00

Total Liabilities=Total Assets (Q: Mar. 2025 )-Total Equity (Q: Mar. 2025 )
=79116-50857
=28,259.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Danaher Total Liabilities Related Terms

Thank you for viewing the detailed overview of Danaher's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Danaher Business Description

Address
2200 Pennsylvania Avenue, North West, Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.